| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
NCI-Navy Medical Oncology [A. F. G., E. K. R., R. I. L., J. L. M.] and Pediatric Oncology Branches [L. J. H., M. A. I.], National Cancer Institute and Naval Hospital, Bethesda, Maryland 20814, and the University of Tennessee [H. M. S.], Knoxville, Tennessee 37901
We evaluated the usefulness of L-dopa decarboxylase (DDC) as a tumor marker of neuroendocrine (NE) cell differentiation by measuring its expression in 432 human tumors of diverse types and origins. A subset of these tumors and cell lines derived from them also were studied for expression of two other general NE cell markers, chromogranin A (CgA) and dense core granules (DCG). High concentrations of DDC were present in 96 of 117 (82%) tumors recognized to be of NE or neural origin. As expected, endocrine tumors not recognized to be of NE cell origin, as well as leukemias, lymphomas, sarcomas, melanomas, and germ cell tumors, lacked DDC expression. Of interest, modest concentrations of DDC were present in 46 of 220 (21%) nonendocrine carcinomas, especially non-small cell lung and colorectal carcinomas. We studied concordant expression of the three NE cell markers in lung and colorectal tumors and cell lines. In both tumor types there was nearly 100% concordance between CgA and DCG expression. There was an excellent correlation between DDC and CgA expression in lung cancers, both small cell and non-small cell, but DDC positive colorectal carcinomas usually lacked CgA expression. We conclude: (a) DDC is an excellent cellular marker for tumors of the NE cell system; (b) about 20% of carcinomas not of NE cell origin, especially non-small cell lung and colorectal carcinomas, express DDC, suggesting a common endodermal origin of all of the respiratory and gastrointestinal mucosal cells; and (c) CgA and DCG are expressed concordantly, indicating that CgA expression may be used as a substitute for ultrastructural examination of tumors for DCG expression.
1 The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Navy or the Department of Defense.
2 To whom requests for reprints should be addressed at NCI-Navy Medical Oncology Branch, Naval Hospital, Bethesda, MD 20814.
3 Present address: Seoul National University, Seoul, Korea.
Received 12/22/87. Revised 4/ 7/88. Accepted 4/13/88.
This article has been cited by other articles:
![]() |
C. Shao, Y. Wang, H.-H. Yue, Y.-T. Zhang, C.-H. Shi, F. Liu, T.-Y. Bao, Z.-Y. Yang, J.-L. Yuan, and G.-X. Shao Biphasic Effect of Androgens on Prostate Cancer Cells and Its Correlation With Androgen Receptor Coactivator Dopa Decarboxylase J Androl, November 1, 2007; 28(6): 804 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kauhanen, M. Seppanen, H. Minn, R. Gullichsen, A. Salonen, K. Alanen, R. Parkkola, O. Solin, J. Bergman, T. Sane, et al. Fluorine-18-L-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or {beta}-Cell Hyperplasia in Adult Patients J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uccella, R. Cerutti, D. Vigetti, D. Furlan, R. Oldrini, I. Carnevali, G. Pelosi, S. La Rosa, A. Passi, and C. Capella Histidine Decarboxylase, DOPA Decarboxylase, and Vesicular Monoamine Transporter 2 Expression in Neuroendocrine Tumors: Immunohistochemical Study and Gene Expression Analysis J. Histochem. Cytochem., August 1, 2006; 54(8): 863 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Becherer, M. Szabo, G. Karanikas, P. Wunderbaldinger, P. Angelberger, M. Raderer, A. Kurtaran, R. Dudczak, and K. Kletter Imaging of Advanced Neuroendocrine Tumors with 18F-FDOPA PET J. Nucl. Med., July 1, 2004; 45(7): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Meijer, S. C.V.M. Copray, H. Hollema, I. P. Kema, N. Zwart, I. Mantingh-Otter, T. P. Links, P. H.B. Willemse, and E. G.E. de Vries Catecholamine-Synthesizing Enzymes in Carcinoid Tumors and Pheochromocytomas Clin. Chem., April 1, 2003; 49(4): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kemp, A. Lewis, M. E. Hartness, G. J. Searle, P. Miller, I. O'Kelly, and C. Peers Airway Chemotransduction: From Oxygen Sensor to Cellular Effector Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S17 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Graff, M. Frungieri, R. Zanner, A. Pohlinger, C. Prinz, and M. Gratzl Expression of Histidine Decarboxylase and Synthesis of Histamine by Human Small Cell Lung Carcinoma Am. J. Pathol., May 1, 2002; 160(5): 1561 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O'Kelly, A. Lewis, C. Peers, and P. J. Kemp O2 Sensing by Airway Chemoreceptor-derived Cells. PROTEIN KINASE C ACTIVATION REVEALS FUNCTIONAL EVIDENCE FOR INVOLVEMENT OF NADPH OXIDASE J. Biol. Chem., March 10, 2000; 275(11): 7684 - 7692. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O'Kelly, R. H. Stephens, C. Peers, and P. J. Kemp Potential identification of the O2-sensitive K+ current in a human neuroepithelial body-derived cell line Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L96 - L104. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O'Kelly, C. Peers, and P. J. Kemp O2-sensitive K+ channels in neuroepithelial body-derived small cell carcinoma cells of the human lung Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L709 - L716. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Missale, A. Codignola, S. Sigala, A. Finardi, M. Paez-Pereda, E. Sher, and P. Spano Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines PNAS, April 28, 1998; 95(9): 5366 - 5371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, C. Youngson, V. Wong, H. Yeger, M. C. Dinauer, E. V.-S. de Miera, B. Rudy, and E. Cutz NADPH-oxidase and a hydrogen peroxide-sensitive K+ channel may function as an oxygen sensor complex in airway chemoreceptors and small cell lung carcinoma cell lines PNAS, November 12, 1996; 93(23): 13182 - 13187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hartness, A. Lewis, G. J. Searle, I. O'Kelly, C. Peers, and P. J. Kemp Combined Antisense and Pharmacological Approaches Implicate hTASK as an Airway O2 Sensing K+ Channel J. Biol. Chem., July 6, 2001; 276(28): 26499 - 26508. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |